Researchers optimized a magnetic bead-based method to detect banned growth hormone-releasing peptides like sermorelin, tesamorelin, and CJC-1295 in urine at extremely low concentrations.
0.2 ng/mL detection limitOptimized method can detect GHRH peptides at sub-nanogram concentrations in human urine
What the researchers found
Optimized magnetic bead immunopurification coupled with LC-HRMS achieved a limit of detection of 0.2 ng/mL and limit of identification of 0.5 ng/mL for GHRH analogues in human urine, with acceptable precision and specificity.
Why it matters
Athletes may misuse growth hormone-releasing peptides to enhance performance. Reliable detection methods at very low concentrations are essential for anti-doping enforcement.
The numbers in context
LOD 0.2 ng/mL; LOI 0.5 ng/mL; intra-day CV <15%; inter-day CV <25%; 4 target peptides
How the study worked
Compared magnetic beads with different surface functionalities, binding capacities, and affinity chemistries for immunopurification. Analyzed by liquid chromatography coupled to Quadrupole-Orbitrap high-resolution mass spectrometry. Full method validation including specificity, precision, matrix effects, and detection limits.
Who was studied
Not applicable (analytical method validation using spiked urine samples)
What this study cannot tell us
Methodology study — does not address prevalence of GHRH doping. Detection limits may still miss very low-level use. Antibody-based methods depend on cross-reactivity with new analogues.
How to read the evidence
Not applicable — this is an analytical methodology study, not a clinical or biological investigation.
When this study was published
Published in 2020; analytical methods for peptide doping detection continue to evolve with new prohibited substances.
The bigger picture
This work supports the broader anti-doping framework by providing analytical tools to detect increasingly sophisticated peptide doping. As more GHRH analogues emerge, detection methods must keep pace.
Questions still open
- Can this method detect newer GHRH analogues not yet on the WADA prohibited list?
- How does this approach compare to non-antibody-based enrichment strategies?
- What is the detection window for these peptides after administration?
Common questions
Why are growth hormone-releasing peptides banned in sports?
Why is detection so difficult?
Read the original research
Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.
Journal of chromatography. A, 1631, 461548
Citation
Pont, Laura; Alechaga, Élida; Terrero, Alejandro; Monfort, Núria; Ventura, Rosa. (2020). Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.. Journal of chromatography. A, 1631, 461548. https://doi.org/10.1016/j.chroma.2020.461548